PPP1R17 Gene Hypercholesterolemia Susceptibility Genetic Test
Components
- Price: 4400.0 AED
- Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
- Report Delivery: 3 to 4 Weeks
- Method: NGS Technology
- Test Type: Metabolic Disorders
- Doctor: General Physician
- Test Department: Genetics
Pre Test Information
Clinical History of Patient who is going for PPP1R17 Gene Hypercholesterolemia, susceptibility to NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with Hypercholesterolemia, susceptibility to.
Test Details
The PPP1R17 gene is associated with susceptibility to hypercholesterolemia, which is a condition characterized by high levels of cholesterol in the blood. NGS (Next-Generation Sequencing) is a genetic testing method that allows for the sequencing of multiple genes simultaneously, providing a comprehensive analysis of an individual’s genetic makeup.
NGS genetic testing for PPP1R17 gene hypercholesterolemia susceptibility involves analyzing the DNA of an individual to identify any variations or mutations in the PPP1R17 gene that may contribute to an increased risk of developing hypercholesterolemia. This information can help healthcare professionals in assessing an individual’s risk of developing the condition and determining appropriate management strategies.
It is important to note that a positive result for PPP1R17 gene hypercholesterolemia susceptibility does not necessarily mean that an individual will develop hypercholesterolemia. Genetic testing provides valuable information about an individual’s genetic predisposition, but other factors such as lifestyle choices and environmental influences also play a role in the development of the condition.
It is recommended to consult with a healthcare professional or a genetic counselor to understand the implications of the test results and to discuss appropriate management strategies based on the individual’s specific genetic profile and overall health.
Test Name | PPP1R17 Gene Hypercholesterolemia susceptibility to Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Metabolic Disorders |
Doctor | General Physician |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for PPP1R17 Gene Hypercholesterolemia, susceptibility to NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with Hypercholesterolemia, susceptibility to |
Test Details |
The PPP1R17 gene is associated with susceptibility to hypercholesterolemia, which is a condition characterized by high levels of cholesterol in the blood. NGS (Next-Generation Sequencing) is a genetic testing method that allows for the sequencing of multiple genes simultaneously, providing a comprehensive analysis of an individual’s genetic makeup. NGS genetic testing for PPP1R17 gene hypercholesterolemia susceptibility involves analyzing the DNA of an individual to identify any variations or mutations in the PPP1R17 gene that may contribute to an increased risk of developing hypercholesterolemia. This information can help healthcare professionals in assessing an individual’s risk of developing the condition and determining appropriate management strategies. It is important to note that a positive result for PPP1R17 gene hypercholesterolemia susceptibility does not necessarily mean that an individual will develop hypercholesterolemia. Genetic testing provides valuable information about an individual’s genetic predisposition, but other factors such as lifestyle choices and environmental influences also play a role in the development of the condition. It is recommended to consult with a healthcare professional or a genetic counselor to understand the implications of the test results and to discuss appropriate management strategies based on the individual’s specific genetic profile and overall health. |